Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Traws Pharma, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 28 | 27 | −1 |
| Shares | 1.78M | 1.82M | +34.3K (+1.9%) |
| Value | $1.27M | $1.35M | +$82.8K (+6.5%) |
New holders (2)
Institutions that held Traws Pharma, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marex Group plc | 148,023 | $110.4K | 0.00% |
| Vermillion & White Wealth Management Group, LLC | 5,133 | $3.83K | 0.00% |
Sold out (3)
Institutions that held Traws Pharma, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 30,713 | $22.2K |
| Two Sigma Securities, LLC | 10,929 | $7.78K |
| Cornerstone Planning Group LLC | 33 | $23 |